Another ATAC-seq peak predicted to regulate BAG3 transcription was found to be significantly associated with cellular resistance to 5-FU and paclitaxel treatment, in line with the results that BAG3 renders cancer cells unresponsive to 5-FU and paclitaxel [38,39]. The gene discussed is BAG3; the disease is cancer.